According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is $1.93 Billion USD. In 2022 the company made a revenue of $1.91 Billion USD a decrease over the revenue in the year 2021 that were of $2.20 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.